Ajanta Pharma posts jump in consolidated PAT to Rs176.63 crores in Q3 FY2020-21
It has has reported total income of Rs.2156.30 crores during the nine months period ended December 31, 2020
Ajanta Pharma has reported financial results for the period ended December 31, 2020.
The company has reported total income of Rs.754.22 crores during the period ended December 31, 2020 as compared to Rs.720.76 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.176.63 crores for the period ended December 31, 2020 as against net profit / (loss) of Rs.170.22 crores for the period ended September 30, 2020.
It has has reported total income of Rs.2156.30 crores during the nine months period ended December 31, 2020 as compared to Rs.1941.41 crores during the nine months period ended December 31, 2019.
The company has posted net profit / (loss) of Rs.494.61 crores for the 9 months period ended December 31, 2020 as against net profit / (loss) of Rs.338.54 crores for the 9 months period ended December 31, 2019.
- Advertisement -